Amgen Inc Stock Price Patterns
| AMGN Stock | USD 342.94 0.72 0.21% |
Momentum 52
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.136 | EPS Estimate Next Quarter 5.0799 | EPS Estimate Current Year 21.2796 | EPS Estimate Next Year 22.1136 | Wall Street Target Price 331.963 |
Using Amgen hype-based prediction, you can estimate the value of Amgen Inc from the perspective of Amgen response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Amgen using Amgen's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Amgen using crowd psychology based on the activity and movement of Amgen's stock price.
Amgen Short Interest
An investor who is long Amgen may also wish to track short interest. As short interest increases, investors should be becoming more worried about Amgen and may potentially protect profits, hedge Amgen with its derivative instruments, or be ready for some potential downside.
200 Day MA 300.1584 | Short Percent 0.026 | Short Ratio 5.1 | Shares Short Prior Month 15 M | 50 Day MA 332.9022 |
Amgen Inc Hype to Price Pattern
Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Amgen's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Amgen.
Amgen Implied Volatility | 0.36 |
Amgen's implied volatility exposes the market's sentiment of Amgen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amgen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amgen stock will not fluctuate a lot when Amgen's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Amgen to buy its stock at a price that has no basis in reality. In that case, they are not buying Amgen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amgen after-hype prediction price | USD 342.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Amgen contract
Based on the Rule 16, the options market is currently suggesting that Amgen Inc will have an average daily up or down price movement of about 0.0225% per day over the life of the 2026-04-17 option contract. With Amgen trading at USD 342.94, that is roughly USD 0.0772 . If you think that the market is fully incorporating Amgen's daily price movement you should consider acquiring Amgen Inc options at the current volatility level of 0.36%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Amgen Basic Forecasting Models to cross-verify your projections. Amgen After-Hype Price Density Analysis
As far as predicting the price of Amgen at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amgen or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amgen, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amgen Estimiated After-Hype Price Volatility
In the context of predicting Amgen's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amgen's historical news coverage. Amgen's after-hype downside and upside margins for the prediction period are 341.08 and 344.80, respectively. We have considered Amgen's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amgen is very steady at this time. Analysis and calculation of next after-hype price of Amgen Inc is based on 3 months time horizon.
Amgen Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Amgen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amgen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amgen, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.27 | 1.87 | 0.79 | 0.00 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
342.94 | 342.94 | 0.00 |
|
Amgen Hype Timeline
Amgen Inc is presently traded for 342.94. The entity has historical hype elasticity of 0.79, and average elasticity to hype of competition of 0.0. Amgen is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 64.04%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.27%. %. The volatility of related hype on Amgen is about 13357.14%, with the expected price after the next announcement by competition of 342.94. About 84.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.1. Amgen Inc recorded earning per share (EPS) of 12.94. The entity last dividend was issued on the 13th of February 2026. The firm had 2:1 split on the 22nd of November 1999. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Amgen Basic Forecasting Models to cross-verify your projections.Amgen Related Hype Analysis
Having access to credible news sources related to Amgen's direct competition is more important than ever and may enhance your ability to predict Amgen's future price movements. Getting to know how Amgen's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amgen may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GILD | Gilead Sciences | 2.04 | 6 per month | 1.34 | 0.11 | 3.01 | (2.41) | 6.70 | |
| PFE | Pfizer Inc | 0.07 | 7 per month | 1.14 | 0.06 | 2.24 | (2.24) | 7.97 | |
| SNY | Sanofi ADR | 0.22 | 9 per month | 0.00 | (0.18) | 1.87 | (2.19) | 5.92 | |
| MRK | Merck Company | (0.91) | 7 per month | 1.14 | 0.17 | 3.59 | (1.98) | 8.09 | |
| DHR | Danaher | 0.20 | 9 per month | 0.00 | (0.05) | 2.30 | (2.11) | 8.05 | |
| BMY | Bristol Myers Squibb | (0.33) | 7 per month | 1.04 | 0.16 | 3.59 | (1.98) | 11.16 | |
| NVO | Novo Nordisk AS | (1.14) | 6 per month | 2.02 | 0.05 | 5.80 | (3.04) | 13.19 | |
| BSX | Boston Scientific Corp | 0.20 | 2 per month | 0.00 | (0.13) | 1.73 | (2.23) | 7.34 | |
| GSK | GlaxoSmithKline PLC ADR | (0.41) | 10 per month | 1.31 | 0.07 | 2.38 | (2.17) | 8.39 | |
| NVS | Novartis AG ADR | 0.20 | 9 per month | 1.13 | 0.11 | 2.59 | (2.32) | 6.07 |
Amgen Additional Predictive Modules
Most predictive techniques to examine Amgen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amgen using various technical indicators. When you analyze Amgen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amgen Predictive Indicators
The successful prediction of Amgen stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amgen Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amgen based on analysis of Amgen hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amgen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amgen's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0296 | 0.0343 | 0.0308 | 0.0191 | Price To Sales Ratio | 5.47 | 4.22 | 4.85 | 8.9 |
Pair Trading with Amgen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Moving against Amgen Stock
| 0.69 | OGEN | Oragenics | PairCorr |
| 0.67 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.64 | XBIO | Xenetic Biosciences | PairCorr |
| 0.51 | ENSC | Ensysce Biosciences | PairCorr |
| 0.4 | DOX | Amdocs Earnings Call This Week | PairCorr |
| 0.33 | SNGX | Soligenix | PairCorr |
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Amgen Basic Forecasting Models to cross-verify your projections. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Biotechnology sector continue expanding? Could Amgen diversify its offerings? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Amgen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.136 | Dividend Share 9.39 | Earnings Share 12.94 | Revenue Per Share | Quarterly Revenue Growth 0.124 |
Investors evaluate Amgen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Amgen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Amgen's market price to deviate significantly from intrinsic value.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.